• Autoimmune Psychosis – Market Insight, Epidemiology, and Market Forecast – 2034

  Nov 11, 2024  |  Published by: DelveInsight  |  USD 7,950

  Autoimmune Psychosis – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight’s “Autoimmune Psychosis Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of the Autoimmune Psychosis, historical and forecasted epidemiology as well as the ... Read More

• Chronic Pseudomonas Aeruginosa Pulmonary Infections - Pipeline Insight, 2024

  Nov 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  Chronic Pseudomonas Aeruginosa Pulmonary Infections - Pipeline Insight, 2024 DelveInsight’s, “Chronic Pseudomonas Aeruginosa Pulmonary Infections - Pipeline Insight, 2024” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Chronic Pseudomonas Aeruginosa Pulmonary In ... Read More

• Hide

  Need some help finding the right information ?
  Verify before you buy
  
  

  
  
  

  or call us
  US toll free: 800.298.5699
  Worldwide: +1.240.747.3093
  
  

• Prostate Cancer - Competitive landscape, 2024

  Nov 01, 2024  |  Published by: DelveInsight  |  USD 5,000

  Prostate Cancer - Competitive landscape, 2024 DelveInsight’s, “Prostate Cancer - Competitive landscape, 2024,” report provides comprehensive insights about 230+ companies and 265+ drugs in Prostate Cancer Competitive landscape. It covers the therapeutics assessment by product type, stage, and route ... Read More

• Non‐cystic fibrosis bronchiectasis - Pipeline Insight, 2024

  Nov 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  Non‐cystic fibrosis bronchiectasis - Pipeline Insight, 2024 DelveInsight’s, “Non‐cystic fibrosis bronchiectasis - Pipeline Insight, 2024” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Non‐cystic fibrosis bronchiectasis pipeline landscape. It covers the pipeline ... Read More

• Familial adenomatous polyposis - Pipeline Insight, 2024

  Nov 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Familial adenomatous polyposis - Pipeline Insight, 2024 DelveInsight’s, “Familial adenomatous polyposis - Pipeline Insight, 2024” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Familial adenomatous polyposis pipeline landscape. It covers the pipeline drug profiles ... Read More

• Smoking Cessation- Pipeline Insight, 2024

  Nov 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  Smoking Cessation- Pipeline Insight, 2024 DelveInsight’s, “Smoking Cessation- Pipeline Insight, 2024” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Smoking Cessation pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical st ... Read More

• Polycystic Kidney Diseases - Pipeline Insight, 2024

  Nov 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  Polycystic Kidney Diseases - Pipeline Insight, 2024 DelveInsight’s, “Polycystic Kidney Diseases - Pipeline Insight, 2024” report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Polycystic Kidney Diseases pipeline landscape. It covers the pipeline drug profiles, including ... Read More

• Alcohol Use Disorder - Pipeline Insight, 2024

  Nov 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Alcohol Use Disorder - Pipeline Insight, 2024 DelveInsight’s, “Alcohol Use Disorder - Pipeline Insight, 2024” report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Alcohol Use Disorder pipeline landscape. It covers the pipeline drug profiles, including clinical and non ... Read More

• Lupus Nephritis - Pipeline Insight, 2024

  Nov 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Lupus Nephritis - Pipeline Insight, 2024 DelveInsight’s, “Lupus Nephritis - Pipeline Insight, 2024” report provides comprehensive insights about 30+ companies and 35+ pipeline drugs in Lupus Nephritis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage ... Read More

• Metastatic Triple-Negative Breast Cancer (mTNBC)- Pipeline Insight, 2024

  Nov 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  Metastatic Triple-Negative Breast Cancer (mTNBC)- Pipeline Insight, 2024 DelveInsight’s, “Metastatic Triple-Negative Breast Cancer (mTNBC)- Pipeline Insight, 2024” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Metastatic Triple-Negative Breast Cancer (mTNBC) pi ... Read More

• Stargardt Disease (STGD)- Pipeline Insight, 2024

  Nov 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Stargardt Disease (STGD)- Pipeline Insight, 2024 DelveInsight’s, “Stargardt Disease (STGD)- Pipeline Insight, 2024” report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in Stargardt Disease (STGD) pipeline landscape. It covers the pipeline drug profiles, including clinic ... Read More

• Dementia Associated With Alzheimer’s Disease - Pipeline Insight, 2024

  Nov 01, 2024  |  Published by: DelveInsight  |  USD 3,000

  Dementia Associated With Alzheimer’s Disease - Pipeline Insight, 2024 DelveInsight’s, “Dementia Associated With Alzheimer’s Disease - Pipeline Insight, 2024” report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in Dementia Associated With Alzheimer’s Disease pipeline la ... Read More

• Type 2 Diabetes - Pipeline Insight, 2024

  Nov 01, 2024  |  Published by: DelveInsight  |  USD 3,000

  Type 2 Diabetes - Pipeline Insight, 2024 DelveInsight’s, “Type 2 Diabetes - Pipeline Insight, 2024” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Type 2 Diabetes pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage ... Read More

• Niemann-Pick disease - Pipeline Insight, 2024

  Nov 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  Niemann-Pick disease - Pipeline Insight, 2024 DelveInsight’s, “Niemann-Pick disease - Pipeline Insight, 2024,” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Niemann-Pick disease pipeline landscape. It covers the pipeline drug profiles, including clinical and no ... Read More

• Cutaneous T-cell lymphoma - Pipeline Insight, 2024

  Nov 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Cutaneous T-cell lymphoma - Pipeline Insight, 2024 DelveInsight’s, “Cutaneous T-cell lymphoma- Pipeline Insight, 2024” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in Cutaneous T-cell lymphoma pipeline landscape. It covers the pipeline drug profiles, including cl ... Read More

• Synovial Sarcoma - Pipeline Insight, 2024

  Nov 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Synovial Sarcoma - Pipeline Insight, 2024 DelveInsight’s, “Synovial Sarcoma- Pipeline Insight, 2024” report provides comprehensive insights about 15+ companies and 20+ pipeline drugs in Synovial Sarcoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stag ... Read More

• Wilson Disease- Pipeline Insight, 2024

  Nov 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Wilson Disease- Pipeline Insight, 2024 DelveInsight’s, “Wilson Disease- Pipeline Insight, 2024” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Wilson Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage product ... Read More

• Cyclin-Dependent Kinase Inhibitor - Pipeline Insight, 2024

  Nov 01, 2024  |  Published by: DelveInsight  |  USD 2,500

  Cyclin-Dependent Kinase Inhibitor - Pipeline Insight, 2024 DelveInsight’s, “Cyclin-Dependent Kinase Inhibitor - Pipeline Insight, 2024” report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Cyclin-Dependent Kinase Inhibitor pipeline landscape. It covers the pipeline d ... Read More

• Lou Gehrig’s disease - Pipeline Insight, 2024

  Nov 01, 2024  |  Published by: DelveInsight  |  USD 3,000

  Lou Gehrig’s disease - Pipeline Insight, 2024 DelveInsight’s, “Lou Gehrig’s disease - Pipeline Insight, 2024” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Lou Gehrig’s disease pipeline landscape. It covers the pipeline drug profiles, including clinical and non ... Read More

• Diabetes - Pipeline Insight, 2024

  Nov 01, 2024  |  Published by: DelveInsight  |  USD 5,000

  Diabetes - Pipeline Insight, 2024 DelveInsight’s, “Diabetes - Pipeline Insight, 2024” report provides comprehensive insights about 200+ companies and 200+ pipeline drugs in Diabetes pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also c ... Read More

• Scars - Pipeline Insight, 2024

  Nov 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  Scars - Pipeline Insight, 2024 DelveInsight’s, “Scars - Pipeline Insight, 2024” report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Scars pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the th ... Read More

• Myotonic Dystrophy - Pipeline Insight, 2024

  Nov 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Myotonic Dystrophy - Pipeline Insight, 2024 DelveInsight’s, “Myotonic Dystrophy - Pipeline Insight, 2024” report provides comprehensive insights about 20+ companies and 27+ pipeline drugs in Myotonic Dystrophy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinic ... Read More

• HPK1 inhibitors - Pipeline Insight, 2024

  Nov 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  HPK1 inhibitors - Pipeline Insight, 2024 DelveInsight’s, “HPK1 inhibitors - Pipeline Insight, 2024” report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in HPK1 inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage ... Read More

• Myositis - Pipeline Insight, 2024

  Nov 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Myositis - Pipeline Insight, 2024 DelveInsight’s, “Myositis - Pipeline Insight, 2024,” report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in Myositis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also co ... Read More

• Ischemic Stroke - Pipeline Insight, 2024

  Nov 01, 2024  |  Published by: DelveInsight  |  USD 2,500

  Ischemic Stroke - Pipeline Insight, 2024 DelveInsight’s, “Ischemic Stroke- Pipeline Insight, 2024” report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in Ischemic Stroke pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage p ... Read More

< prev 1 2 3 4 5 6 7 8 9 10 next >